U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449390) titled 'Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole' on Feb. 27.
Brief Summary: The primary objective of the trial is to assess the effect of multiple doses of the cytochrome P450 (CYP3A4) enzyme inducer carbamazepine (Part A) or the CYP3A4 inhibitor itraconazole (Part B) on the single-dose pharmacokinetics (PK) of AP31969 in healthy participants.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AP31969
Oral tablets.
DRUG: Carbamazepine
Oral capsules.
DRUG: Itraconazole
Oral tablets.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Acesion Phar...